Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Nicola A Hanania, Suzanne C. Lareau & Barbara P. Yawn. (2017) Safety of inhaled long-acting anti-muscarinic agents in COPD. Postgraduate Medicine 129:5, pages 500-512.
Read now
Read now
Ching Kuo Tan, Gui Quan Say & James B Geake. (2016) Long-term safety of tiotropium delivered by Respimat® SoftMist™ Inhaler: patient selection and special considerations. Therapeutics and Clinical Risk Management 12, pages 1433-1444.
Read now
Read now
Donald Banerji, Donald A. Mahler & Nicola A. Hanania. (2016) Efficacy and safety of LABA/LAMA fixed-dose combinations approved in the US for the management of COPD. Expert Review of Respiratory Medicine 10:7, pages 767-780.
Read now
Read now
Pinar Yildiz, Mesut Bayraktaroglu, Didem Gorgun & Funda Secik. (2016) Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trial. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2859-2867.
Read now
Read now
Luigino Calzetta, Chiara Ciaprini, Ermanno Puxeddu & Mario Cazzola. (2016) Olodaterol + tiotropium bromide for the treatment of COPD. Expert Review of Respiratory Medicine 10:4, pages 379-386.
Read now
Read now
Guy Brusselle, David Price, Kevin Gruffydd-Jones, Marc Miravitlles, Dorothy L Keininger, Rebecca Stewart, Michael Baldwin & Rupert C Jones. (2015) The inevitable drift to triple therapy in COPD: an analysis of prescribing pathways in the UK. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2207-2217.
Read now
Read now
Wijdan H Ramadan, Wissam K Kabbara, Ghada M El Khoury & Sarah A Al Assir. (2015) Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 10, pages 2347-2356.
Read now
Read now
Emily M. Armstrong, Bradley M. Wright, Allison Meyer, Courtney S. Watts & Kristi W. Kelley. (2014) The Role of Aclidinium Bromide in the Treatment of Chronic Obstructive Pulmonary Disease. Hospital Practice 42:4, pages 99-110.
Read now
Read now
Stephen Newman. (2014) Improving inhaler technique, adherence to therapy and the precision of dosing: major challenges for pulmonary drug delivery. Expert Opinion on Drug Delivery 11:3, pages 365-378.
Read now
Read now
Articles from other publishers (18)
Huaye Gao, Jintong Li, Xiaoping Chen, Zhanguo Sun, Gang Cui, Minlu Cheng & Li Ding. (2022) Pharmacokinetics, metabolite profiling, safety, and tolerability of inhalation aerosol of 101BHG-D01, a novel, long-acting and selective muscarinic receptor antagonist, in healthy Chinese subjects. Frontiers in Pharmacology 13.
Crossref
Crossref
Yuanzi Xu. (2022) The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease. The Analysis of Tiotropium bromide and Roflumilast: Two Potent Medications for Chronic Obstructive Pulmonary Disease.
Luigino Calzetta, Beatrice Ludovica Ritondo, Maria Cristina Zappa, Gian Marco Manzetti, Andrea Perduno, Janis Shute & Paola Rogliani. (2022) The impact of long-acting muscarinic antagonists on mucus hypersecretion and cough in chronic obstructive pulmonary disease: a systematic review. European Respiratory Review 31:164, pages 210196.
Crossref
Crossref
Fernanda Borowsky da Rosa, Adriane Schmidt Pasqualoto, Catriona M. Steele & Renata Mancopes. (2020) Oral and Oropharyngeal Sensory Function in Adults With Chronic Obstructive Pulmonary Disease. American Journal of Speech-Language Pathology 29:2, pages 864-872.
Crossref
Crossref
Donald Banerji, Robert Fogel & Francesco Patalano. (2018) Indacaterol/glycopyrronium: a dual bronchodilator for COPD. Drug Discovery Today 23:1, pages 196-203.
Crossref
Crossref
Ursula Kirchmayer, Silvia Cascini, Nera Agabiti, Mirko Di Martino, Lisa Bauleo, Giulio Formoso, Claudio Voci, Riccardo Pistelli, Elisabetta Patorno & Marina Davoli. (2016) One‐year mortality associated with COPD treatment: a comparison of tiotropium and long‐acting beta2‐agonists in three Italian regions: results from the OUTPUL study. Pharmacoepidemiology and Drug Safety 25:5, pages 578-589.
Crossref
Crossref
Roy A. Pleasants, Tiansheng Wang, Jinming Gao, Huilin Tang & James F. Donohue. (2016) Inhaled Umeclidinium in COPD Patients: A Review and Meta-Analysis. Drugs 76:3, pages 343-361.
Crossref
Crossref
Kevin Gruffydd-Jones, Guy Brusselle, Rupert Jones, Marc Miravitlles, Michael Baldwin, Rebecca Stewart, Anna Rigazio, Emily Davis, Dorothy L Keininger & David Price. (2016) Changes in initial COPD treatment choice over time and factors influencing prescribing decisions in UK primary care: a real-world study. npj Primary Care Respiratory Medicine 26:1.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
357
381
.
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
227
241
.
N M Nenasheva. (2015) New opportunities for treatment of severe bronchial asthma: from clinical studies to portraits of patients. Russian Journal of Allergy 12:3, pages 51-61.
Crossref
Crossref
A S Kolbin, T L Galankin, M A Proskurin & Y E Balykina. (2015) Pharmacoeconomic analysis of using of tiotropium bromide (Spiriva® Respimat®) as adjunctive therapy in patients with asthma in the Russian Federation. Russian Journal of Allergy 12:5, pages 49-58.
Crossref
Crossref
Yogesh Suresh Punekar, Graeme Roberts, Afisi Ismaila & Martin O’Leary. (2015) Cost-effectiveness of umeclidinium/vilanterol combination therapy compared to tiotropium monotherapy among symptomatic patients with chronic obstructive pulmonary disease in the UK. Cost Effectiveness and Resource Allocation 13:1.
Crossref
Crossref
O M Kurbacheva, S A Polner & D S Smirnov. (2014) BRONCHOLITIC THERAPY IN BRONCHIAL ASTHMA: PROPER CHOICE. Russian Journal of Allergy 11:5, pages 28-35.
Crossref
Crossref
Katie E. Baker, Sara J. Bonvini, Chantal Donovan, Rachel E. Foong, Bing Han, Aruni Jha, Yasin Shaifta, Marieke Smit, Jill R. Johnson & Lyn M. Moir. (2014) Novel drug targets for asthma and COPD: Lessons learned from in vitro and in vivo models. Pulmonary Pharmacology & Therapeutics 29:2, pages 181-198.
Crossref
Crossref
Gillian M. Keating. (2014) Tiotropium Respimat® Soft Mist™ Inhaler: A Review of Its Use in Chronic Obstructive Pulmonary Disease. Drugs 74:15, pages 1801-1816.
Crossref
Crossref
Daniel J. Hassett, Michael T. Borchers & Ralph J. Panos. (2014) Chronic obstructive pulmonary disease (COPD): Evaluation from clinical, immunological and bacterial pathogenesis perspectives. Journal of Microbiology 52:3, pages 211-226.
Crossref
Crossref
A. Kirsten & H. Watz. (2014) LABA, LAMA und KombinationenLABA, LAMA and combinations. Der Pneumologe 11:2, pages 127-134.
Crossref
Crossref